NE

Natasha Emer

Natasha Emer


Senior Finance Manager



Professional Overview
Natasha Emer is an accomplished Senior Finance Manager with over 20 years of experience in the pharmaceutical and consumer goods industries. She leverages her expertise in financial analysis, strategic planning, and operational optimization to drive significant value for her organization.

Experience Summary

Current Role
As the Senior Finance Manager at Celgene, Natasha is responsible for overseeing the company's financial planning, budgeting, and forecasting processes. She collaborates closely with cross-functional teams to provide strategic financial insights that support informed decision-making and enhance operational efficiency. Under her leadership, Natasha has implemented data-driven reporting mechanisms that have improved financial visibility and enabled the organization to make more strategic, data-driven decisions.

Career Progression
Natasha's career has been marked by progressive roles in the finance domain. Prior to joining Celgene, she held senior financial analyst positions at inVentiv Health, Johnson & Johnson, and Biovail Pharmaceuticals, where she demonstrated her ability to analyze complex financial data, optimize resource allocation, and drive operational improvements. Earlier in her career, Natasha gained valuable experience as a Financial Analyst at Bayer Consumer Care and Nabisco, Inc.

Academic Background
Natasha holds a Bachelor of Science in Finance from the University of Pennsylvania, where she graduated with distinction. She has also completed executive training programs in strategic financial management and leadership development, further enhancing her industry expertise and managerial capabilities.

Areas of Expertise
  • Financial analysis and reporting

  • Budgeting and forecasting

  • Strategic planning and decision support

  • Process improvement and operational optimization

  • Cross-functional collaboration and stakeholder management


Professional Impact
During her tenure at Celgene, Natasha has led the implementation of a new financial reporting system that has improved data accuracy, streamlined decision-making, and enhanced the organization's ability to respond to market changes. Her strategic financial insights have contributed to the successful launch of several new drug products, resulting in significant revenue growth and increased shareholder value.

Conclusion
Natasha Emer is a highly accomplished finance professional with a proven track record of driving tangible business impact. Her expertise in financial analysis, strategic planning, and operational optimization, coupled with her strong leadership skills, make her a valuable asset to her organization. Natasha is poised to continue her trajectory of success, contributing to the ongoing growth and success of Celgene and the broader pharmaceutical industry.